Ahmedabad-based manufacturer of generic pharmaceutical formulations — dry powder injections, B-Lactam and general tablets/capsules, and ORS — sold in bulk to marketers and traders, domestically and abroad.
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 0 | 1 | 8 | 11 | 11 | 33 | 33 | 33 |
| Reserves | 5 | 6 | 3 | 21 | 25 | 6 | 9 | 13 |
| Borrowings | 9 | 17 | 16 | 7 | 6 | 11 | 11 | 22 |
| Other Liabilities | 10 | 5 | 21 | 10 | 15 | 22 | 32 | 39 |
| Total Liabilities | 24 | 29 | 48 | 49 | 57 | 72 | 86 | 106 |
| AssetsFixed Assets | 5 | 6 | 7 | 7 | 12 | 12 | 12 | 15 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 19 | 23 | 41 | 42 | 44 | 60 | 74 | 92 |
| Total Assets | 24 | 29 | 48 | 49 | 57 | 72 | 86 | 106 |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | -3 | 3 | -6 | 2 | -9 | 8 | -4 | -4 |
| Cash from Investing | -1 | -3 | -2 | -1 | 1 | -6 | 0 | -4 |
| Cash from Financing | 4 | 0 | 7 | -1 | 8 | -2 | 4 | 9 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | -4 | 0 | -8 | 1 | -9 | 2 | -4 | -8 |
| FCF Margin | — | — | — | — | — | — | — | — |
This looks cyclical, and we don't have enough quarters to establish a through-cycle earnings base. Valuing it off the current point in the cycle would be misleading.
JFLLIFE · CYCLICAL_UNMODELABLE
Guides on how to read this kind of business and the numbers that matter.